On the Horizon - upcoming first generic launches*

Mid 2020 AFINITOR 10mg everolimus Cancer $394 M
1H2020 SAPHRIS asenapine Mental/Neuro disorders $120 M
1H2020 APTENSIO XR methylphenidate ER Attention disorders $19 M
7/28/20 TACLONEX suspension calcipotriene/betamethasone Plaque psoriasis $56 M
9/29/20 TYKERB lapatinib Cancer $66 M
9/30/20 ATRIPLA efavirenz/emtricitabine/tenofovir disoproxil fumarate HIV $1,273 M
9/30/20 TRUVADA (200/300) emtricitabine/tenofovir disoproxil fumarate HIV $3,160 M
10/1/20 KUVAN sapropterin dihydrochloride Endocrine disorders $43 M
11/26/20 RISPERDAL CONSTA risperidone microspheres Mental/Neuro disorders $413 M
12/6/20 OFIRMEZ acetaminophen intravenous Pain/Inflammation $342 M
12/27/20 ABSORICA isotretinoin Acne $308 M
2H2020 ENTEREG alvimopan Constipation $103 M
2H2020 FORTEO teriparatide Osteoporosis $941 M
2H2020 KORLYM mifepristone Endocrine disorders $251 M
2H2020 TIROSINT levothyroxine sodium capsule Thyroid disorders $85 M
2020 BYETTA exenatide Diabetes $187 M
2020 CIPRODEX OTIC ciprofloxacin/dexamethasone Ear infections $436 M
2020 RESTASIS cyclosporine ophthalmic Ophthalmic conditions $1,768 M
2020-2021 TOVIAZ fesoterodine fumarate Urinary disorders $219 M

* M = Millions, IMS Sales 2018

Legal Disclaimer | Privacy | Product Disclosures | Cigna Company Names

Health benefit plans vary, but in general to be eligible for coverage a drug must be approved by the Food and Drug Administration (FDA), prescribed by a health care professional, purchased from a licensed pharmacy and medically necessary. Some plans require use an in-network pharmacy for prescriptions to be covered. Coverage is subject to any plan deductible, copayment and/or coinsurance requirements. Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and complete details of prescription drug coverage, contact a Cigna representative.

All Cigna products and services are provided exclusively by or through operating subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance Company, (CHLIC), Cigna Behavioral Health, Inc., Cigna Health Management, Inc., Accredo Health Group, Inc., Express Scripts, Inc., ESI Mail Pharmacy Service, Inc., Express Scripts Pharmacy, Inc., Tel-Drug, Inc., Tel-Drug of Pennsylvania, L.L.C., Lynnfield Drug, Inc., and HMO or service company subsidiaries of Cigna Health Corporation. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. (CHLIC). The Cigna name, logo, and other Cigna marks are trademarks of Cigna Intellectual Property, Inc. "Express Scripts" is a trademark of Express Scripts Strategic Development, Inc. This newsletter is not intended for residents of New Mexico.

© 2020 Cigna. All rights reserved